Jiang S - Search Results

1

Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitors.

Liu S, Zhao Q, Jiang S. Liu S, et al. Among authors: jiang s. Peptides. 2003 Sep;24(9):1303-13. doi: 10.1016/j.peptides.2003.07.013. Peptides. 2003. PMID: 14706544

2

Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1).

Neurath AR, Strick N, Jiang S. Neurath AR, et al. Among authors: jiang s. Virology. 1992 May;188(1):1-13. doi: 10.1016/0042-6822(92)90729-9. Virology. 1992. PMID: 1373549

3

Peptides mimicking selected disulfide loops in HIV-1 gp120, other than V3, do not elicit virus-neutralizing antibodies.

Neurath AR, Strick N, Fields R, Jiang S. Neurath AR, et al. Among authors: jiang s. AIDS Res Hum Retroviruses. 1991 Aug;7(8):657-62. doi: 10.1089/aid.1991.7.657. AIDS Res Hum Retroviruses. 1991. PMID: 1718344

4

Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.

Neurath AR, Jiang S, Strick N, Kolbe H, Kieny MP, Muchmore E, Girard M. Neurath AR, et al. Among authors: jiang s. AIDS Res Hum Retroviruses. 1991 Oct;7(10):813-23. doi: 10.1089/aid.1991.7.813. AIDS Res Hum Retroviruses. 1991. PMID: 1720628

5

Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.

Jiang SB, Lin K, Neurath AR. Jiang SB, et al. J Exp Med. 1991 Dec 1;174(6):1557-63. doi: 10.1084/jem.174.6.1557. J Exp Med. 1991. PMID: 1836013 Free PMC article.

6

Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.

Neurath AR, Strick N, Lin K, Jiang S. Neurath AR, et al. Among authors: jiang s. AIDS Res Hum Retroviruses. 1995 Jun;11(6):687-96. doi: 10.1089/aid.1995.11.687. AIDS Res Hum Retroviruses. 1995. PMID: 7576928

7

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

Debnath AK, Jiang S, Strick N, Lin K, Haberfield P, Neurath AR. Debnath AK, et al. Among authors: jiang s. J Med Chem. 1994 Apr 15;37(8):1099-108. doi: 10.1021/jm00034a007. J Med Chem. 1994. PMID: 8164251

8

Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.

Jiang S, Lin K, Strick N, Neurath AR. Jiang S, et al. Biochem Biophys Res Commun. 1993 Sep 15;195(2):533-8. doi: 10.1006/bbrc.1993.2078. Biochem Biophys Res Commun. 1993. PMID: 8373393

9

Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence.

Jiang S, Lin K. Jiang S, et al. Pept Res. 1995 Nov-Dec;8(6):345-8. Pept Res. 1995. PMID: 8838418

10

A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein.

Jiang S, Lin K, Lu M. Jiang S, et al. J Virol. 1998 Dec;72(12):10213-7. doi: 10.1128/JVI.72.12.10213-10217.1998. J Virol. 1998. PMID: 9811763 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,833 results

Search Page

Filters